Rainbow Childrens Medicare
NSE: RAINBOW · ISIN INE961O01016 · Healthcare
₹1,265.00−5.40 (−0.43%)
Monday 9 November, 13:16 IST. Delayed. Source: Yahoo Finance.
Price chart
₹1,265.00 −5.40 (−0.43%) today
The day
- Previous close
- ₹1,270.40
- Open
- ₹1,270.00
- Day high
- ₹1,278.00
- Day low
- ₹1,240.80
Listed on NSE since 10 May 2022.
Key numbers
- Market value
- ₹12,589 Cr
- P/E (trailing)
- 43.21
- EPS (trailing)
- ₹28.80
- Price to book
- 7.36
- Dividend yield
- 0.28%
- Return on equity
- 18.3%
- Debt to equity
- 0.56
- Profit margin
- 15.2%
- Beta
- 0.19
- Volume today
- 40,657
- Average volume
- 1.26 L
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹1,160.80 Cr | ₹210.83 Cr |
| FY24 | ₹1,285.69 Cr | ₹217.00 Cr |
| FY25 | ₹1,495.01 Cr | ₹243.42 Cr |
| FY26 | ₹1,677.71 Cr | ₹278.32 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | ₹548 Cr | ₹82 Cr | +9.1% |
| Q1 FY27Apr–Jun 2026 | ₹470 Cr | ₹61 Cr | +13.2% |
| Q4 FY26Jan–Mar 2026Audited | ₹460 Cr | ₹77 Cr | +36.8% |
| Q3 FY26Oct–Dec 2025 | ₹445 Cr | ₹73 Cr | – |
| Q2 FY26Jul–Sep 2025 | ₹445 Cr | ₹75 Cr | – |
| Q1 FY26Apr–Jun 2025 | ₹353 Cr | ₹53 Cr | – |
Source: Rainbow Childrens Medicare’s results filed with NSE, consolidated (the whole group). Net profit is the share of Rainbow Childrens Medicare’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | September 2026 | March 2026 |
|---|---|---|
| Fixed assets | ₹1,772 Cr | ₹1,637 Cr |
| Investments | ₹354 Cr | ₹404 Cr |
| Inventories | ₹54 Cr | ₹42 Cr |
| Owed by customers | ₹133 Cr | ₹103 Cr |
| Cash and equivalents | ₹33 Cr | ₹34 Cr |
| Total assets | ₹2,959 Cr | ₹2,775 Cr |
| Borrowings | ₹0 | ₹0 |
| Total liabilities | ₹1,223 Cr | ₹1,111 Cr |
| Shareholders’ equity | ₹1,714 Cr | ₹1,648 Cr |
Source: Rainbow Childrens Medicare’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.
About Rainbow Childrens Medicare
Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers medical and healthcare services to children and women. It also provides pediatric services under brand Rainbow Children's Hospital which include newborn and pediatric intensive care; pediatric multi-specialty services; and pediatric quaternary care, such as multi-organ transplantation. In addition, the company offers women care services under Birthright brand that comprise perinatal care services, such as routine and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility support, and a range of gynecology treatments, as well as operates private pediatric DNB (Diplomate of National Board) training program offering postgraduate and fellowship opportunities to train future healthcare professionals. Rainbow Children's Medicare Limited was incorporated in 1998 and is based in Hyderabad, India.
- Industry
- Medical Care Facilities
- Based in
- Hyderabad
- Employees
- 4,724
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Rainbow Childrens Medicare in the last day or two.
Dividends and corporate actions
All companies- Dividend - Rs 3.50 Per Share
Dividend · ex-date 21 July 2026
- Dividend - Rs 3 Per Share
Dividend · ex-date 27 June 2025 · record date 28 June 2025
- Annual General Meeting/Dividend - Rs 3 Per Share
Dividend · ex-date 23 July 2024
- Annual General Meeting/Dividend - Rs 3 Per Share
Dividend · ex-date 22 June 2023
- Annual General Meeting/Dividend - Rs 2 Per Share
Dividend · ex-date 7 September 2022 · record date 8 September 2022
Source: NSE. Latest first.
Information only, not investment advice. Prices are delayed.